BIOMAT Database Logo BIOMAT Database Logo

The natural history of recurrent herpes simplex labialis: implications for antiviral therapy. 1977

S L Spruance, and J C Overall, and E R Kern, and G G Krueger, and V Pliam, and W Miller

We performed daily examination of 80 patients with recurrent herpes simplex labialis to define the course of the disease and to identify quantitative and objective measurements for use in monitoring the efficacy of antiviral chemotherapy. Pain, lesion size, mean virus titers from lesion swabs (10(5) plaque-forming units [PFU]) and frequency of virus-positive lesions (89 per cent) were maximal during the first 24 hours and decreased thereafter. Lesion punch-biopsy virus titers increased from a mean of less than 10(1) PFU in the prodromal and erythema stages to a mean of 10(4.7) in the vesicle stage. MEasurements potentially useful in monitoring antiviral efficacy include: time to loss of crust, time to complete healing, intensity and duration of lesion pain, area defined by lesion virus titer and duration of lesion virus excretion, and maximum lesion virus titer after the first visit. Early application of topical antiviral therapy should theoretically be able to alter the course of this disease.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010146 Pain An unpleasant sensation induced by noxious stimuli which are detected by NERVE ENDINGS of NOCICEPTIVE NEURONS. Suffering, Physical,Ache,Pain, Burning,Pain, Crushing,Pain, Migratory,Pain, Radiating,Pain, Splitting,Aches,Burning Pain,Burning Pains,Crushing Pain,Crushing Pains,Migratory Pain,Migratory Pains,Pains, Burning,Pains, Crushing,Pains, Migratory,Pains, Radiating,Pains, Splitting,Physical Suffering,Physical Sufferings,Radiating Pain,Radiating Pains,Splitting Pain,Splitting Pains,Sufferings, Physical
D012008 Recurrence The return of a sign, symptom, or disease after a remission. Recrudescence,Relapse,Recrudescences,Recurrences,Relapses
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D005260 Female Females
D006560 Herpes Labialis Herpes simplex, caused by type 1 virus, primarily spread by oral secretions and usually occurring as a concomitant of fever. It may also develop in the absence of fever or prior illness. It commonly involves the facial region, especially the lips and the nares. (Dorland, 27th ed.) Cold Sore,Fever Blister,Herpes Simplex, Labial,Blister, Fever,Blisters, Fever,Cold Sores,Fever Blisters,Labial Herpes Simplex,Sore, Cold,Sores, Cold
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000287 Administration, Topical The application of drug preparations to the surfaces of the body, especially the skin (ADMINISTRATION, CUTANEOUS) or mucous membranes. This method of treatment is used to avoid systemic side effects when high doses are required at a localized area or as an alternative systemic administration route, to avoid hepatic processing for example. Drug Administration, Topical,Administration, Topical Drug,Topical Administration,Topical Drug Administration,Administrations, Topical,Administrations, Topical Drug,Drug Administrations, Topical,Topical Administrations,Topical Drug Administrations

Related Publications

S L Spruance, and J C Overall, and E R Kern, and G G Krueger, and V Pliam, and W Miller
[Lysine therapy of recurrent herpes simplex labialis].
October 1979, Ugeskrift for laeger,
S L Spruance, and J C Overall, and E R Kern, and G G Krueger, and V Pliam, and W Miller
Natural history of frequent recurrences of herpes simplex labialis.
November 1988, Oral surgery, oral medicine, and oral pathology,
S L Spruance, and J C Overall, and E R Kern, and G G Krueger, and V Pliam, and W Miller
[Levamisole in the therapy of recurrent herpes simplex labialis].
April 1980, Centro de Estudios de Recursos Odontologicos para el Nino : CERON,
S L Spruance, and J C Overall, and E R Kern, and G G Krueger, and V Pliam, and W Miller
Antiviral therapy for recurrent herpes simplex reconsidered.
January 1997, Dermatology (Basel, Switzerland),
S L Spruance, and J C Overall, and E R Kern, and G G Krueger, and V Pliam, and W Miller
Surveillance for antiviral-agent-resistant herpes simplex virus in the general population with recurrent herpes labialis.
September 2002, Antimicrobial agents and chemotherapy,
S L Spruance, and J C Overall, and E R Kern, and G G Krueger, and V Pliam, and W Miller
Herpes simplex labialis history defined. Antiviral drug therapy may help. New tests aid multiple sclerosis diagnosis.
March 1978, JAMA,
S L Spruance, and J C Overall, and E R Kern, and G G Krueger, and V Pliam, and W Miller
Recurrent facial urticaria following herpes simplex labialis.
March 2012, Indian journal of dermatology,
S L Spruance, and J C Overall, and E R Kern, and G G Krueger, and V Pliam, and W Miller
Recurrent herpes simplex labialis: selected therapeutic options.
September 2003, Journal (Canadian Dental Association),
S L Spruance, and J C Overall, and E R Kern, and G G Krueger, and V Pliam, and W Miller
'Hairy sunscreen' for the prevention of recurrent herpes simplex labialis.
January 1992, The Journal of dermatological treatment,
S L Spruance, and J C Overall, and E R Kern, and G G Krueger, and V Pliam, and W Miller
Evaluation of antiviral treatments for recurrent herpes simplex labialis in the dorsal cutaneous guinea pig model.
August 1988, Antiviral research,
Copied contents to your clipboard!